-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KEISUGS608qcqyt1TFnwun3s6kM3amkNQmZIfEjNgvJpJcGQLoIn7Q4RAl1V5vXr SETGPFiKSu0Ti2vYie+mSw== 0000897101-99-000756.txt : 19990811 0000897101-99-000756.hdr.sgml : 19990811 ACCESSION NUMBER: 0000897101-99-000756 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19990803 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRASCIENCE INC CENTRAL INDEX KEY: 0000727672 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411448837 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-59395 FILM NUMBER: 99676881 BUSINESS ADDRESS: STREET 1: 3650 ANNAPOLIS LANE STREET 2: STE 101 CITY: MINNEAPOLIS STATE: MN ZIP: 55447-5434 BUSINESS PHONE: 6125099999 MAIL ADDRESS: STREET 1: 3650 ANNAPOLIS LANE STREET 2: STE 101 CITY: MINNETONKA STATE: MN ZIP: 55447-5434 FORMER COMPANY: FORMER CONFORMED NAME: GV MEDICAL INC DATE OF NAME CHANGE: 19920703 RW 1 SPECTRASCIENCE(TM), Inc. [LOGO] SPECTRASCIENCE 3650 Annapolis Lane, Suite 101 Minneapolis, Minnesota 55447-5434 USA Tel: 612 509 9999 Fax: 612 509 9805 July 28, 1999 Michael K. Ferraro Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: SPECTRASCIENCE, Inc. Registration Statement on Form SB-2 SEC File No. 333-59395 Dear Mr. Ferraro: On behalf of SPECTRASCIENCE, Inc. (the "Company"), we hereby apply to withdraw the Company's Registration Statement on Form SB-2 (the "Registration Statement"). The Registration Statement has not been declared effective. The Company is withdrawing the Registration Statement because market conditions have not been conducive to an offering of the Company's Common Stock. No securities have been offered or sold pursuant to the Registration Statement. With regard to the open issues raised by the Commission in its letter dated October 20, 1998, the Company has the following responses: 1. The Company does not believe that the loss of Portlyn Corporation as a supplier would have a material adverse effect on the Company. 2. No additional disclosure is required since the Registration Statement is being withdrawn. 3. The Company filed the initial MIT License Agreement as Exhibit 10,11 to its Quarterly Report on Form 10-Q for the quarter ended March 31, 1990. The Company represents that it will file any amendments to the MIT License Agreement in its Quarterly Report on Form 10-Q for the quarter ended June 30, 1999. If you have any questions regarding this request, please feel free to contact the undersigned at (612) 509-9999, ext. 208, or Theodore C. Cadwell, Jr. of Dorsey & Whitney LLP at (612) 343-2160. Thank you. Sincerely, /s/ CHESTER E. SIEVERT, JR. - --------------------------- Chester E. Sievert, Jr. President and Chief Executive Officer -----END PRIVACY-ENHANCED MESSAGE-----